Súkeníková, L. http://orcid.org/0000-0002-1605-1609
Mallone, A. http://orcid.org/0000-0002-7949-9718
Schreiner, B.
Ripellino, P. http://orcid.org/0000-0002-8662-9656
Nilsson, J.
Stoffel, M. http://orcid.org/0000-0003-1304-5817
Ulbrich, S. E.
Sallusto, F.
Latorre, D. http://orcid.org/0000-0003-1031-1534
Article History
Received: 16 March 2023
Accepted: 30 November 2023
First Online: 17 January 2024
Competing interests
: The authors declare no competing financial interests. P.R. is a member of the advisory boards for Roche, Biogen, Alexion and Argenx Pharmaceuticals, all of which are not connected to this project.